Chemoinformaics analysis of Delphinidin 3-O-beta-D-sambubioside
| Molecular Weight | 597.502 | nRot | 6 |
| Heavy Atom Molecular Weight | 568.27 | nRig | 20 |
| Exact Molecular Weight | 597.145 | nRing | 5 |
| Solubility: LogS | -7.195 | nHRing | 3 |
| Solubility: LogP | 7.732 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 71 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 42 | No. of Aromatic Carbocycles | 2 |
| nHetero | 16 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 29 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 26 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 16 | No. of Arom Bond | 17 |
| nHA | 15 | APOL | 75.589 |
| nHD | 11 | BPOL | 37.773 |
| QED | 0.422 |
| Synth | 4.68 |
| Natural Product Likeliness | 2.842 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.112 |
| Pgp-sub | 0 |
| HIA | 0.006 |
| CACO-2 | -4.726 |
| MDCK | 0.0000055 |
| BBB | 0.926 |
| PPB | 0.992253 |
| VDSS | 1.977 |
| FU | 0.01127 |
| CYP1A2-inh | 0.044 |
| CYP1A2-sub | 0.505 |
| CYP2c19-inh | 0.066 |
| CYP2c19-sub | 0.944 |
| CYP2c9-inh | 0.088 |
| CYP2c9-sub | 0.337 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.587 |
| CYP3a4-inh | 0.189 |
| CYP3a4-sub | 0.706 |
| CL | 16.859 |
| T12 | 0.007 |
| hERG | 0.019 |
| Ames | 0.025 |
| ROA | 0.131 |
| SkinSen | 0.024 |
| Carcinogencity | 0.02 |
| EI | 0.009 |
| Respiratory | 0.666 |
| NR-Aromatase | 0.005 |
| Antiviral | Yes |
| Prediction | 0.764501 |